Liquidia (LQDA) Cash from Investing Activities (2020 - 2026)
Liquidia (LQDA) recorded quarterly Cash from Investing Activities of -$2.8 million in Q1 2026, up 29.92% quarter-over-quarter from -$4.0 million in Q4 2025, and down 757.58% on a YoY basis from $430368.7 in Q1 2025.
Liquidia (LQDA) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Liquidia's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$2.8 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 757.58% year-over-year to -$2.8 million; the TTM figure through Mar 2026 stood at -$8.8 million (down 8.46% YoY), while the FY2025 annual figure was -$6.3 million, up 24.94% from the prior year.
- Cash from Investing Activities was -$2.8 million for Q1 2026 at Liquidia, up from -$4.0 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$2000.0 in Q2 2022 to a low of -$10.5 million in Q3 2023.
- Historically, Cash from Investing Activities has averaged -$1.8 million across 5 years, with a median of -$767500.0 in 2024.
- The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities soared 94.29% in 2022, then tumbled 12050.0% in 2023.
- A 5-year view of Cash from Investing Activities shows it stood at -$491000.0 in 2022, then surged by 58.04% to -$206000.0 in 2023, then tumbled by 2220.39% to -$4.8 million in 2024, then increased by 15.52% to -$4.0 million in 2025, then climbed by 29.92% to -$2.8 million in 2026.
- The last three Cash from Investing Activities figures came in at -$2.8 million (Q1 2026), -$4.0 million (Q4 2025), and -$911000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.45 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 25.99 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | -2.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.83 Mn |
| Mar 31, 2026 | -2.83 Mn |
| Dec 31, 2025 | -4.04 Mn |
| Dec 31, 2025 | -4.04 Mn |
| Sep 30, 2025 | -911,000.00 |
| Sep 30, 2025 | -911,000.00 |
| Jun 30, 2025 | -1.06 Mn |
| Jun 30, 2025 | -1.06 Mn |
| Mar 31, 2025 | -330,000.00 |
| Mar 31, 2025 | -330,000.00 |
| Dec 31, 2024 | -4.78 Mn |
| Dec 31, 2024 | -4.78 Mn |
| Sep 30, 2024 | -1.75 Mn |
| Sep 30, 2024 | -1.75 Mn |
| Jun 30, 2024 | -1.29 Mn |
| Jun 30, 2024 | -1.29 Mn |
| Mar 31, 2024 | -624,000.00 |
| Mar 31, 2024 | -624,000.00 |
| Dec 31, 2023 | -206,000.00 |
| Dec 31, 2023 | -206,000.00 |